Skip to main content
GRML
NASDAQ Life Sciences

Shareholders to Vote on Reverse Stock Split to Avoid Nasdaq Delisting

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.39
Mkt Cap
$46.713M
52W Low
$0.16
52W High
$3.91
52W Position info
144% above low
Off High info
90% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

GRML has more than doubled off its 52-week low of $0.16.

Summary

Greenland Mines Ltd will hold a special meeting on June 18, 2026, for shareholders to vote on a reverse stock split, a necessary step to meet Nasdaq's minimum bid price requirement and avoid delisting.


Key Events · Corporate Governance and Compliance · GRML

  • Reverse Stock Split Proposal

    Shareholders will vote on a proposal to effect one or more reverse stock splits, with an exchange ratio between 1-for-2 and 1-for-50, and an aggregate maximum of 1-for-60, to be determined by the Board of Directors.

  • Nasdaq Compliance Critical

    The primary purpose of the reverse stock split is to increase the per share market price to meet Nasdaq's $1.00 minimum bid price requirement, following a delisting threat and an extension until September 14, 2026.

  • Special Meeting Scheduled

    A virtual Special Meeting of Stockholders is scheduled for June 18, 2026, to vote on the reverse stock split and a proposal to adjourn the meeting if needed to solicit additional proxies.

  • Board Discretion on Ratio and Timing

    If approved, the Board will have the discretion to implement the reverse stock split at any time until March 31, 2027, and to select the specific ratio within the approved range without further shareholder approval.


Analysis · GRML · Life Sciences

Greenland Mines Ltd is seeking shareholder approval for a reverse stock split, with a potential ratio up to 1-for-60, to increase its share price and regain compliance with Nasdaq's minimum bid price requirement. This action is critical for the company to maintain its listing, especially given its recent history of financial distress and a "going concern" warning.

At the time of this filing, GRML was trading at $0.39 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $46.7M. The 52-week trading range was $0.16 to $3.91. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

GRML - Latest Insights

GRML
Jul 28, 2026, 12:37 PM EDT
Source: FinanceWire
Importance Score:
7
Price at Filing: $0.190
Real-time Price: $0.1901 info
Change: +$0.0001 (+0.05%) info
Market Cap: $30.442M info
GRML
Jul 27, 2026, 2:11 PM EDT
Source: FinanceWire
Importance Score:
7
Price at Filing: $0.179
Real-time Price: $0.1901 info
Change: +$0.0111 (+6%) info
Market Cap: $30.442M info
GRML
Jul 23, 2026, 9:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.228
Real-time Price: $0.1901 info
Change: -$0.0379 (-17%) info
Market Cap: $30.442M info
GRML
Jul 20, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.190
Real-time Price: $0.1901 info
Change: +$0.0001 (+0.05%) info
Market Cap: $30.442M info
GRML
Jul 17, 2026, 11:12 AM EDT
Filing Type: 4
Importance Score:
8
Price at Filing: $0.184
Real-time Price: $0.1901 info
Change: +$0.0061 (+3%) info
Market Cap: $30.442M info